D49.7, Neoplasm of unspecified behavior of endocrine glands and other parts of nervous systemICD-10-CM
No Prior Auth Required
Code is covered without prior authorization (high confidence)
CGS-J15-L34394, Visual Fields Testing
J15
CGS-J15-L40386, Erythropoiesis Stimulating Agents (ESA)
J15
CGS-J15-L36658, Proton Beam Therapy
J15
CGS-J15-L34356, Erythropoiesis Stimulating Agents (ESA)
J15
CGS-J15-L36021, MolDX: Molecular Diagnostic Tests (MDT)
J15
CGS-J18-L36658, Proton Beam Therapy
J18
CGS-J18-L34394, Visual Fields Testing
J18
CGS-J18-L34356, Erythropoiesis Stimulating Agents (ESA)
J18
CGS-J18-L40386, Erythropoiesis Stimulating Agents (ESA)
J18
CGS-J18-L36021, MolDX: Molecular Diagnostic Tests (MDT)
J18
A55147, Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID Update
J5
WPS-J5-L36807, MolDX: Molecular Diagnostic Tests (MDT)
J5
NGS-J6-L35075, Proton Beam Therapy
J6
NGS-J6-L33574, Visual Fields Testing
J6
NGS-J6-L40333, Erythropoiesis Stimulating Agents
J6
NGS-J6-L36850, Peripheral Nerve Blocks
J6
NGS-J6-L35076, Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)
J6
NGS-J6-L40334, Erythropoiesis Stimulating Agents
J6
A56551, Billing and Coding: Visual Fields Testing
J6
A56827, Billing and Coding: Proton Beam Therapy
J6
Ask Backwork about documentation requirements, denial risks, or coverage in your state.